McKesson Pays $82M To End Drug Price Inflation Suit
McKesson Corp. on Wednesday agreed to pay $82 million to resolve a Massachusetts class action brought by several municipalities accusing the pharmaceutical distributor of scheming to fraudulently inflate prices of more...To view the full article, register now.
Already a subscriber? Click here to view full article